Tryp Therapeutics Strengthens Board of Directors With Appointment of Gregory M. McKee Post published:January 14, 2021 Post category:Press Release
NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials Post published:January 14, 2021 Post category:Press Release
Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol Post published:January 14, 2021 Post category:Press Release
Red Light Holland Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended September 30, 2020 and Material Change Report Post published:January 14, 2021 Post category:Press Release
Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore Post published:January 13, 2021 Post category:Press Release
PharmaTher Approved to Trade on the OTCQB Venture Market Post published:January 13, 2021 Post category:Press Release
Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board Post published:January 13, 2021 Post category:Press Release
Novamind Expands Psychedelic Medicine Access in Utah Post published:January 13, 2021 Post category:Press Release
Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectrometer Post published:January 13, 2021 Post category:Press Release
Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences Post published:January 13, 2021 Post category:Press Release